Associate Director: Compound Management Group AstraZeneca
Matt has been employed by AstraZeneca Boston for the past 8 years. His role in the organization consists of being: a Team Leader for the Compound Management Group (CMG), the Boston Biobank Site Head, and Chair of the Global Innovations and Technologies Team (GLINT).
Matt is an innovative visionary with 18 years of successive career advancement in the life sciences industry, focused on automated platform development, process improvement, and value chain optimization. Before joining AstraZeneca in 2007, he held posts at other pharmaceutical companies, most recently the former Schering-Plough Research Institute and Cubist Pharmaceuticals.
Matt graduated from Sacred Heart University in CT with a Bachelor of Science degree in Biology, and earned an MBA degree from Northeastern University after having completed their High Technology Program. He has also enjoyed Executive Education Programs at the Wharton School of the University of Pennsylvania, Harvard Business School, and MIT’s Sloan School of Management.